Your browser doesn't support javascript.
loading
The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity
Brooke E Nichols; Lise Jamieson; Sabrina RC Zhang; Sheetal Silal; Juliet Pulliam; Ian Sanne; Gesine Meyer-Rath.
Afiliación
  • Brooke E Nichols; Boston University School of Public Health
  • Lise Jamieson; Health Economics and Epidemiology Research Office, Johannesburg, South Africa
  • Sabrina RC Zhang; Massachusetts College of Pharmacy and Health Sciences
  • Sheetal Silal; Modelling and Simulation Hub, Africa, Department of Statistical Sciences, University of Cape Town
  • Juliet Pulliam; f. South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa
  • Ian Sanne; Health Economics and Epidemiology Research Office, Johannesburg, South Africa
  • Gesine Meyer-Rath; Department of Global Health, Boston University School of Public Health
Preprint en En | PREPRINT-MEDRXIV | ID: ppmedrxiv-20127084
ABSTRACT
Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of COVID-19 patients requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.
Licencia
cc_no
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Idioma: En Año: 2020 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Idioma: En Año: 2020 Tipo del documento: Preprint